Your session is about to expire
← Back to Search
Behavioral Intervention
Cognitive Processing Therapy for Substance Use Disorders
N/A
Waitlist Available
Led By Melissa Zielinski, Phd
Research Sponsored by University of Arkansas
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
18 years of age or older
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up pre-treatment assessments will be completed within 4 weeks of treatment start. post-treatment assessments will be completed within 2 weeks of treatment end. post-release assessments will be completed approximately 3 months after release from prison.
Awards & highlights
No Placebo-Only Group
Summary
This trial will study whether a specific therapy can help reduce drug use, psychiatric symptoms, and recidivism for people who have been incarcerated.
Who is the study for?
This trial is for adults over 18 who are incarcerated in Arkansas, within 9 months of release, and have a history of substance use disorder and trauma. They must understand English, consent to participate, and be able to provide contact information post-release.
What is being tested?
The study tests Cognitive Processing Therapy (CPT) for treating trauma in incarcerated drug users compared to a control therapy focused on coping. It aims to see if CPT can reduce drug use, psychiatric symptoms, and recidivism.
What are the potential side effects?
While the trial does not involve medication with physical side effects, participants may experience emotional discomfort or distress while discussing traumatic experiences during therapy sessions.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am 18 years old or older.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ pre-treatment assessments will be completed within 4 weeks of treatment start. post-treatment assessments will be completed within 2 weeks of treatment end. post-release assessments will be completed approximately 3 months after release from prison.
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~pre-treatment assessments will be completed within 4 weeks of treatment start. post-treatment assessments will be completed within 2 weeks of treatment end. post-release assessments will be completed approximately 3 months after release from prison.
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Change in PTSD Symptoms by Treatment End and 3 Months Post-Release from Incarceration
Post-Incarceration Drug Use
Secondary study objectives
Change in Depression Symptoms by Treatment End and 3 Months Post-Release from Incarceration
Recidivism
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Cognitive Processing Therapy (CPT)Experimental Treatment1 Intervention
CPT is a gold-standard evidence-based psychotherapy for PTSD that combines education about trauma with strategies to challenge the trauma-related cognitions that are theorized to maintain PTSD symptoms. It can be delivered in group and individual formats, but will be delivered in a group format in this project due to feasibility in the setting. Structure will be based on feedback obtained during completion of Aim 2 while remaining within the range evaluated in prior research (i.e., 8-12 sessions, 1-2x per week, each lasting 1.5-2 hours).
Group II: Coping Skills GroupActive Control1 Intervention
The Coping Skills Group will match for attention and dose, without adding any cost to the system. Exact content will be determined during completion of Aim 2; however, project sites already provide coping-focused programming and coping-skill approaches to trauma treatment are a common alternative to evidence-based therapies for PTSD, such as CPT, that deal more directly with the index trauma. To provide an enhanced standard of care, the investigator will review treatment materials (workbooks, handouts) already used in prison settings and arrange a curriculum of skills similar to those in coping-focused trauma-informed interventions (e.g., psychoeducation, assertiveness).
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Cognitive Processing Therapy
2016
N/A
~4030
Find a Location
Who is running the clinical trial?
National Institute on Drug Abuse (NIDA)NIH
2,586 Previous Clinical Trials
3,328,382 Total Patients Enrolled
University of ArkansasLead Sponsor
494 Previous Clinical Trials
150,182 Total Patients Enrolled
Melissa Zielinski, PhdPrincipal InvestigatorUniversity of Arkansas
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You have symptoms of PTSD that are confirmed by a special interview with a doctor.I was released from jail or prison within the last 9 months.The PI has invited specific people to participate in the study due to their roles at the treatment sitesYou have a history of drug addiction before being put in prison.Prisoners in Arkansas are often held in either the East Central Arkansas Community Correction Center or the Northeast Arkansas Community Correction Center.I am 18 years old or older.You have a history of drug or alcohol addiction before being in jail.You have experienced a traumatic event and are currently struggling with ongoing trauma-related problems.
Research Study Groups:
This trial has the following groups:- Group 1: Cognitive Processing Therapy (CPT)
- Group 2: Coping Skills Group
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Share this study with friends
Copy Link
Messenger